Product Name | MF | CAS | Details |
---|
Thalidomide-O-amido-PEG2-C2-NH2 TFA | C23H27F3N4O10 | 1957235-75-4 | Details |
(S,R,S)-AHPC-C4-NH2 hydrochloride | C27H40ClN5O4S | 2245697-83-8 | Details |
E3 Ligase Ligand-Linker Conjugates 52 (TFA) | C20H21F3N4O8 | 2022182-58-5 | Details |
(S,R,S)-AHPC-Me-C5-COOH | C30H42N4O6S | 2229976-21-8 | Details |
(S,R,S)-AHPC-C10-NH2 | C33H51N5O4S | 2341796-74-3 | Details |
DT2216 | C77H96ClF3N10O10S4 | 2365172-42-3 | Details |
(2S,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxylicacid | C16H28N2O6 | 630421-46-4 | Details |
ARV-771 | C49H60ClN9O7S2 | 1949837-12-0 | Details |
(S,R,S)-AHPC-Me hydrochloride | C23H33ClN4O3S | 1948273-03-7 | Details |
E3 ligase Ligand-Linker Conjugates 7 | C32H50ClN5O8S | 2064292-52-8 | Details |
Thalidomide-O-amido-C4-N3 | C19H20N6O6 | 2098488-36-7 | Details |
CCT367766 | C49H48ClN7O11 | 2229856-58-8 | Details |
2-(2,6-dioxopiperidin-3-yl)-4-hydroxyisoindoline-1,3-dione | C13H10N2O5 | 64567-60-8 | Details |
E3 ligase Ligand-Linker Conjugates 5 Free Base | C30H45N5O7S | 2010159-56-3 | Details |
BSJ-03-123 | C47H56N10O11 | 2361493-16-3 | Details |
(S,R,S)-AHPC-C10-NH2 dihydrochloride | C33H52ClN5O4S | 2341796-75-4 | Details |
(S,R,S)-AHPC-C4-NH2 | C27H39N5O4S | 2138439-53-7 | Details |
(S,R,S)-AHPC-O-Ph-PEG1-NH2 | C32H41N5O6S | 2361117-24-8 | Details |
1-TOSYL-1H-PYRROLO[2,3-B]PYRIDINE-4-BORONIC ACID PINACOL ESTER | C20H23BN2O4S | 916176-50-6 | Details |
4-[5-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PYRIDIN-2-YL]-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER | C20H32BN3O4 | 496786-98-2 | Details |
MDK7526 | C22H30N4O3S | 1448297-52-6 | Details |
E3 ligase Ligand 1A | C23H32N4O3S | 1948273-02-6 | Details |
(S,R,S)-AHPC-PEG1-N3 | C26H35N7O5S | 2101200-09-1 | Details |
JQEZ5 | C30H38N8O2 | 1913252-04-6 | Details |
BRD4 degrader AT1 | C48H58ClN9O5S3 | 2098836-45-2 | Details |
VH032-PEG5-C6-Cl | C38H59ClN4O9S | 1799506-06-1 | Details |
PROTAC BRD9 Degrader-1 | C42H45N7O12S2 | 2097971-01-0 | Details |
Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride | C21H27ClN4O8 | 2376990-30-4 | Details |
PROTAC BRD4 Degrader-5 | C50H62ClN9O8S2 | 2409538-70-9 | Details |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-triMethyl-, (6R)- | C19H17ClN4O2S | 202592-24-3 | Details |
2-(2,6-dioxopiperidin-3-yl)-5-fluoroisoindoline-1,3-dione | C13H9FN2O4 | 835616-61-0 | Details |
I-BET762 carboxylic acid | C20H17ClN4O3 | 1300019-38-8 | Details |
(3R)-4-(2-chloro-6-[(methylsulfinyl)methyl]-4-pyrimidinyl)-3-methylmorpholine | C11H16ClN3O2S | 1352227-18-9 | Details |
dBET57 | C34H31ClN8O5S | 1883863-52-2 | Details |
(S)-AZD6738 | C20H24N6O2S | 1352226-87-9 | Details |
Pomalidomide-C2-NH2 hydrochloride | C15H17ClN4O4 | 2305369-00-8 | Details |
(S,R,S)-AHPC-PEG5-COOH | C36H54N4O11S | 2172820-14-1 | Details |
Pomalidomide-amido-PEG3-C2-NH2 | C22H28N4O8 | 2328070-52-4 | Details |
MS1943 | C42H54N8O3 | 2225938-17-8 | Details |
PROTAC SGK3 degrader-1 | C57H73FN10O11S2 | 2381320-35-8 | Details |
1-METHYL-4-[5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABORALAN-2-YL)PYRIDINE-2-YL]PIPERAZINE | C16H26BN3O2 | 918524-63-7 | Details |
2-(2,6-dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione | C13H9FN2O4 | 835616-60-9 | Details |
(R)-methyl 2-chloro-6-(3-methylmorpholino)pyrimidine-4-carboxylate | C11H14ClN3O3 | 1233339-69-9 | Details |
MS4078 | C45H52ClN9O8S | 2229036-62-6 | Details |
(S,R,S)-AHPC-PEG2-NH2 | C28H41N5O6S | 2010159-60-9 | Details |
(S,R,S)-AHPC | C23H32N4O3S | 2055344-67-5 | Details |
(S,R,S)-AHPC-C4-NH2 dihydrochloride | C27H40ClN5O4S | 2341796-78-7 | Details |
Pomalidomide-PEG4-C-COOH | C23H29N3O10 | 2097938-44-6 | Details |
MZ 1 | C49H60ClN9O8S2 | 1797406-69-9 | Details |
Thalidomide-O-amido-C3-COOH | C19H19N3O8 | 2308035-51-8 | Details |
(S,R,S)-AHPC-PEG3-NH2 hydrochloride | C30H46ClN5O7S | 2097971-11-2 | Details |
E3 Ligase Ligand-Linker Conjugates 20 (TFA) | C25H31F3N4O8 | 1950635-16-1 | Details |
(S)-JQ-35 | C27H34ClN7OS | 1349719-98-7 | Details |
Pomalidomide-PEG3-C2-NH2 | C21H28N4O7 | 2093416-31-8 | Details |
Thalidomide-O-amido-C6-NH2 hydrochloride | C21H27ClN4O6 | 2376990-31-5 | Details |
1-isopropyl-1H-pyrazol-3-amine | C6H11N3 | 857267-04-0 | Details |
(R)-(-)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate | C23H25ClN4O2S | 1268524-71-5 | Details |
Protein degrader 1 hydrochloride | C22H31ClN4O3S | 1448189-80-7 | Details |
(S,R,S)-AHPC-(C3-PEG)2-C6-Cl | C39H61ClN4O6S | 1835705-61-7 | Details |
Thalidomide-O-amido-C4-NH2 hydrochloride | C19H23ClN4O6 | 2245697-86-1 | Details |
Thalidomide-NH-C4-NH2 TFA | C19H21F3N4O6 | 2093387-50-7 | Details |
5-Bromo-2-(4-Boc-piperazin-1-yl)pyridine | C10H14BrN3 | 364794-58-1 | Details |
5,8,11-Trioxa-2-azatridecanoic,13-amino,1,1-dimethylethyl ester | C13H28N2O5 | 101187-40-0 | Details |
(3R)-4-[2-chloro-6-(methylsulfanylmethyl)pyrimidin-4-yl]-3-methylmorpholine | C11H16ClN3OS | 1352227-15-6 | Details |
(S,R,S)-AHPC-PEG4-NH2 | C32H49N5O8S | 2010159-57-4 | Details |
A1874 | C58H62Cl3F2N9O7S | 2064292-12-0 | Details |
(S,R,S)-AHPC-PEG2-NH2 dihydrochloride | C28H42ClN5O6S | 2341796-76-5 | Details |
(R)-(2-chloro-6-(3-methylmorpholino)pyrimidin-4-yl)-methanol | C10H14ClN3O2 | 1233339-70-2 | Details |
(S,R,S)-AHPC-PEG2-NH2 hydrochloride | C28H42ClN5O6S | 2097973-72-1 | Details |
(S,R,S)-AHPC-PEG4-N3 | C32H47N7O8S | 1797406-81-5 | Details |
E3 Ligase Ligand-Linker Conjugates 25 TFA | C23H27F3N4O8 | 1950635-14-9 | Details |
TD-165 | C46H59N7O8S | 2305936-56-3 | Details |
4-(3-Pyridyl)-2-chloropyrimidine | C9H6ClN3 | 483324-01-2 | Details |
AP20187 | C82H107N5O20 | 195514-80-8 | Details |
5-(6-(3-methoxyoxetan-3-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine | C19H22N6O3S | 1394076-92-6 | Details |
(S,R,S)-AHPC-C6-NH2 | C29H43N5O4S | 2306389-03-5 | Details |
(S,R,S)-AHPC-PEG3-N3 | C30H43N7O7S | 1797406-80-4 | Details |
Thalidomide-O-amido-PEG-C2-NH2 hydrochloride | C19H23ClN4O7 | 2204226-02-6 | Details |
PROTAC K-Ras Degrader-1 | C53H62N10O10 | 2378258-52-5 | Details |
1-ISOPROPYL-3-METHYL-6-OXO-6,7-DIHYDRO-1H-PYRAZOLO[3,4-B]PYRIDINE-4-CARBOXYLIC ACID | C11H13N3O3 | 1160246-29-6 | Details |
VH032-PEG3-acetylene | C31H42N4O7S | 2098799-80-3 | Details |
E3 Ligase Ligand-Linker Conjugates 2 | C27H32N4O8 | 1818885-63-0 | Details |
Thalidomide-NH-C4-NH-Boc | C22H28N4O6 | 2093388-52-2 | Details |
Pomalidomide-PEG1-C2-N3 | C17H18N6O5 | 2271036-44-1 | Details |
Thalidomide-O-amido-PEG3-C2-NH2 | C23H30N4O9 | 1957236-20-2 | Details |
(S,R,S)-AHPC-PEG2-N3 | C28H39N7O6S | 2010159-45-0 | Details |
(S,R,S)-AHPC-C5-COOH | C29H42N4O5S | 2267282-19-7 | Details |
(S,R,S)-AHPC-Me TFA | C25H33F3N4O5S | 2349429-68-9 | Details |
(S,R,S)-AHPC TFA | C24H31F3N4O5S | 1631137-51-3 | Details |
(S,R,S)-AHPC-Me-C10-NH2 | C34H53N5O4S | 2376139-52-3 | Details |
(S,R,S)-AHPC-C3-NH2 | C26H37N5O4S | 2361119-88-0 | Details |
3-((1R,3S,5S)-3-((7-((5-Methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile | C22H26N8 | 2051918-33-1 | Details |
PROTAC BET Degrader-1 | C44H45N11O9 | 2093386-22-0 | Details |
Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride | C23H31ClN4O9 | 2245697-84-9 | Details |
3,6,9-trioxaundecamethylenediamine | C8H20N2O3 | 929-75-9 | Details |
(3R)-4-(2-chloro-6-(1-((R)-S-methylsulfonimidoyl)cyclopropyl)pyrimidin-4-yl)-3-methylmorpholine | C13H19ClN4O2S | 1352282-87-1 | Details |
(R)-4-(2-chloro-6-(iodomethyl)pyrimidin-4-yl)-3-methylmorpholine | C10H13ClIN3O | 1233339-72-4 | Details |
(R)-(2-chloro-6-(3-methylmorpholino)pyrimidin-4-yl)methyl methanesulfonate | C11H16ClN3O4S | 1233339-71-3 | Details |
(S,R,S)-AHPC-Me-C6-NH2 | C30H45N5O4S | 2411422-49-4 | Details |
Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride | C25H35ClN4O10 | 2245697-85-0 | Details |
Product Total: Product Page: | ||||
57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 |